Patents by Inventor Mark D. Soll
Mark D. Soll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230087923Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: August 23, 2022Publication date: March 23, 2023Applicant: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 11464763Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: September 3, 2020Date of Patent: October 11, 2022Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20210128533Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: September 3, 2020Publication date: May 6, 2021Applicant: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 10786487Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: January 14, 2019Date of Patent: September 29, 2020Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 10383854Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: October 5, 2016Date of Patent: August 20, 2019Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20190216784Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: January 14, 2019Publication date: July 18, 2019Applicant: MERIAL, INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 9877950Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: November 3, 2015Date of Patent: January 30, 2018Assignee: MERIAL INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20170020849Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: October 5, 2016Publication date: January 26, 2017Applicant: MERIAL, INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20160051519Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: November 3, 2015Publication date: February 25, 2016Applicant: MERIAL, INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 9180121Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: September 12, 2012Date of Patent: November 10, 2015Assignee: MERIAL, INC.Inventors: Mark D. Soll, James Pate, Natalya Shub
-
Publication number: 20130065846Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: September 12, 2012Publication date: March 14, 2013Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Motwani-Tejwani, Carol Belansky
-
Patent number: 8362086Abstract: The application relates to long acting injectable (LAI) formulations for combating ectoparasites and endoparasites in mammals. In particular, this invention provides for a LAI formulation comprising a subcutaneously volatile solvent, a biologically acceptable polymer, a bioactive agents and optionally one or more anti-ectoparasitically or anti-endoparasitically acceptable additive or excipient. Surprisingly, the liquid long acting injectable formulations of the invention solve the problems associates with previous injectable formulations by having long term stability, being able to accommodate smaller needle diameters and achieving long acting effects in the control of pests in a mammal. The unique formulations of the invention also allow for combating ectoparasites and endoparasites which have become resistant to macrolide antibiotics.Type: GrantFiled: August 19, 2005Date of Patent: January 29, 2013Assignee: Merial LimitedInventors: Mark D. Soll, Peter Hanson, Krishan Kumar, Monica Tejwani-Motwani
-
Publication number: 20130023490Abstract: The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.Type: ApplicationFiled: July 23, 2012Publication date: January 24, 2013Inventors: Albert BOECKH, Luiz Gustavo CRAMER, Mark D. SOLL
-
Patent number: 8242161Abstract: The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.Type: GrantFiled: April 8, 2009Date of Patent: August 14, 2012Assignee: Merial LimitedInventors: Albert Boeckh, Luiz Gustavo Cramer, Mark D. Soll
-
Patent number: 7919522Abstract: Provided is a novel ivermectin derivative and compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise: (A) a pharmaceutically effective amount of a 1-N-phenylpyrazole compound; (B) a pharmaceutically effective amount of an ivermectin derivative of formula (II) wherein: R14 represents —(CH2)s—O—Z wherein, s is 1 or 2; Y represents —CH(OR15)—, —C(?O)— or —C(?NOR15); R15 represents hydrogen, alkyl or phenyl; and R16 represents —CH3 or —CH2CH3; Z is alkyl, alkenyl, alkynyl, acyl, alkylalkoxy, aryl, alkanoyloxy, alkoxycarbonyl, alkenoyl, alkynoyl, or aroyl.Type: GrantFiled: May 3, 2007Date of Patent: April 5, 2011Assignee: Merial LimitedInventors: Mark D. Soll, Albert Boeckh, Natalya Shub
-
Publication number: 20090192207Abstract: The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.Type: ApplicationFiled: April 8, 2009Publication date: July 30, 2009Inventors: Albert Boeckh, Luiz Gustavo Cramer, Mark D. Soll
-
Patent number: 7531186Abstract: The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.Type: GrantFiled: February 20, 2004Date of Patent: May 12, 2009Assignee: Merial LimitedInventors: Albert Boeckh, Luiz Gustavo Cramer, Mark D. Soll
-
Publication number: 20080160067Abstract: This document relates to formulations for combating bacterial infections in animals which provide for improved long-acting oral and injectable formulations for systemic delivery of antibiotics, which are designed to achieve high bioavailability.Type: ApplicationFiled: September 5, 2007Publication date: July 3, 2008Inventors: Albert Boeckh, Mark D. Soll, Monica Tejwani-Motwani, Robert P. Waranis, Fangjun Wu
-
Patent number: 6998131Abstract: In particular this invention provides for spot-on compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise: (1) a composition comprising (A) an effective amount of a 1-phenylpyrazole derivative; and (B) an effective amount of emamectin; (2) an acceptable liquid carrier vehicle; and (3) optionally, a crystallization inhibitor. The invention also provides for a method of treating parasitic infestations or for the prophylaxis of parasite infestations in mammals or birds which comprises topically applying to said mammal treating parasitic infestations or for the prophylaxis of parasite infestations in mammals or birds which comprises topically applying to said mammal or bird an effective amount of a composition according to the present invention.Type: GrantFiled: October 24, 2002Date of Patent: February 14, 2006Assignee: Merial LimitedInventors: Mark D. Soll, Albert Boeckh
-
Patent number: 6991801Abstract: This invention provides for inter alia, topical anthelmintic formulations which comprise a pharmaceutically active combination consisting of at least one macrocyclic compound and at least one compound selected from the group consisting of praziquantel, morantel and pyrantel, which are dissolved in a non-aqueous solvent or solvent mixture and optionally a thickening agent.Type: GrantFiled: April 5, 2004Date of Patent: January 31, 2006Assignee: Merial LimitedInventors: Mark D. Soll, Krishan Kumar, Robert P. Waranis, Natalya Shub